CHELSEY SCHNEIDER: Open Payments
NPI 1992068555 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 27 payments from 11 companies in 2025. Trend: 2023 $786 · 2024 $538 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $144 |
| Amgen Inc. | 7 | $127 |
| Philips North America LLC | 1 | $33 |
| Merck Sharp & Dohme LLC | 2 | $28 |
| Abbott Laboratories | 1 | $22 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Novo Nordisk Inc | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
Products named: REPATHA, ELIQUIS, Ambulatory Monitoring & Diagnostics Undivided, VERQUVO, VYNDAQEL, CARDIOMEMS, LifeVest, CAMZYOS.
Industry payments across ND — which companies pay providers there.
